Klotho Neurosciences, Inc.
KLTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9 | $1,076 | $1,076 | $1,076 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $0 |
| Enterprise Value | $10 | $1,078 | $1,077 | $1,076 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.32 | -0.001 | -0.001 | -0.001 |
| % Growth | -45,614.3% | -16.7% | 45.5% | – |
| Operating Cash Flow | -$3 | -$0 | -$1 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$3 | -$0 | -$1 | -$0 |